サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1485770

プラスミドDNA受託製造市場：プラスミドサイズ・複雑度別、サービスタイプ別、治療領域別、用途別、国別、地域別-産業分析、市場規模、市場シェア、2024年～2032年予測

Plasmid DNA Contract Manufacturing Market, By Plasmid Size and Complexity, By Service Type, By Therapeutic Area, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
プラスミドDNA受託製造市場：プラスミドサイズ・複雑度別、サービスタイプ別、治療領域別、用途別、国別、地域別-産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年04月13日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

プラスミドDNA受託製造市場規模は2023年に3億8,154万米ドルとなり、2024～2032年にかけてCAGR 19.43%で拡大

プラスミドDNA受託製造市場-市場力学

プラスミド（pDNA）DNAの需要増加と市場主要企業による研究開発活動の活発化

プラスミドDNAの需要は、著名な市場参入企業による研究開発活動の活発化により、顕著な高まりを見せています。この動向は、遺伝子治療、ワクチン開発、遺伝子工学など、さまざまなバイオテクノロジー用途におけるプラスミドDNAの重要性が高まっていることを示しています。さらに、製造受託機関もプラスミドDNA市場の拡大に貢献しています。こうした取り組みは、満たされていない医療ニーズに対応し、バイオテクノロジーセグメントの技術革新を促進することを目的としています。

プラスミドDNA受託製造市場-主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024～2032年）に約19.43%のCAGRで毎年成長すると予測されています。

プラスミドのサイズ・複雑度のセグメンテーション別では、大型プラスミドが2023年に最大の市場シェアを示すと予測されました。

サービスタイプ別では、プラスミドDNA製造が2023年の主要タイプでした。

治療領域別では、2023年には腫瘍学が主要タイプとなっています。

地域別では、北米が2023年の売上高でトップ

プラスミドDNA受託製造市場-セグメンテーション分析：

世界のプラスミドDNA受託製造市場は、プラスミドサイズ・複雑度、サービスタイプ、治療領域、用途、地域に基づいてセグメント化されます。

市場はプラスミドサイズ・複雑度に基づいて3つのカテゴリーに分けられます：プラスミドには様々なサイズと複雑さがあり、様々な遺伝子工学的ニーズに対応しています。小型プラスミドは基本的な遺伝子工学作業に理想的なコンパクトなDNA分子であり、大型プラスミドはより大きな遺伝子運搬能力を提供し、高度なバイオテクノロジー用途に適しています。

市場はサービスタイプによって4つのカテゴリーに分けられます：プラスミドDNA受託製造は、生産、最適化、試験、製剤化を含む多様なサービスを記載しています。プラスミドDNA受託製造は、生産、最適化、試験、製剤化など多様なサービスを記載しています。分析試験は製品の品質を保証し、製剤化と充填仕上げサービスは製品を流通させるための準備を行う。

プラスミドDNA受託製造市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

北米は、バイオテクノロジー企業や製薬企業のプレゼンスが高く、規制の枠組みも整っているため、市場シェアでリードしています。欧州は、研究開発への旺盛な投資と確立されたバイオ製造インフラにより、僅差でこれに続く。アジア太平洋は、バイオテクノロジーと受託製造サービスへの投資の増加により、大きな成長の可能性を示しています。

プラスミドDNA受託製造市場-競合情勢：

主要参入企業には、 Aldevron、Catalent、Thermo Fisher Scientificなど、確立されたバイオ医薬品受託製造会社（CMO）が数社含まれます。これらの企業はプラスミドDNAの生産から精製、分析試験まで包括的なサービスを提供しています。さらに、新興のCMOやバイオテクノロジー新興企業は、専門的な知識やニッチなサービスを提供し、市場の多様性に貢献しています。受託製造業者とバイオテクノロジー企業との競合は、各社が革新的なソリューションを提供し、世界の足跡を拡大しようと努力する中で、さらに競争を激化させています。

目次

第1章 プラスミドDNA受託製造市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 プラスミドDNA受託製造の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 プラスミドDNA受託製造産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 プラスミドDNA受託製造市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 プラスミドDNA受託製造市場情勢

  • プラスミドDNA受託製造市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 プラスミドDNA受託製造市場-プラスミドサイズ・複雑度別

  • 概要
    • プラスミドサイズ・複雑度別セグメントシェア分析
    • 小型プラスミド
    • 大型プラスミド
    • 複合プラスミド（例：ウイルスベクター）

第8章 プラスミドDNA受託製造市場-サービスタイプ別

  • 概要
    • サービスタイプ別セグメントシェア分析
    • プラスミドDNA製造
    • プロセス開発と最適化
    • 分析試験と品質管理
    • 配合と充填・仕上げサービス
    • その他

第9章 プラスミドDNA受託製造市場-治療領域別

  • 概要
    • 治療領域別セグメントシェア分析
    • 腫瘍学
    • 遺伝性疾患
    • 感染症
    • 希少疾患
    • 自己免疫疾患
    • その他

第10章 プラスミドDNA受託製造市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • 遺伝子治療
    • ワクチン
    • 細胞療法
    • タンパク質生産
    • 研究開発
    • その他

第11章 プラスミドDNA受託製造市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-プラスミドDNA受託製造業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Aldevron, LLC
    • Catalent, Inc.
    • Cell and Gene Therapy Catapult（CGT Catapult）
    • Cobra Biologics（Cognate BioServicesの子会社）
    • Codex DNA, Inc.
    • Eurofins Scientific
    • Fujifilm Diosynth Biotechnologies
    • Kaneka Corporation
    • Lonza Group Ltd.
    • MilliporeSigma（Merck KGaAの事業）
    • PlasmidFactory GmbH &Co. KG
    • Sirion Biotech GmbH
    • Thermo Fisher Scientific Inc.
    • VGXI, Inc.（GeneOne Life Science Inc.の子会社）
    • Wuxi Biologics
    • その他

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Plasmid DNA Contract Manufacturing Market: Plasmid Size and Complexity Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Plasmid Size and Complexity
  • TABLE Global Plasmid DNA Contract Manufacturing Market, by Plasmid Size and Complexity 2019-2032 (USD Million)
  • TABLE Plasmid DNA Contract Manufacturing Market: Service Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Service Type
  • TABLE Global Plasmid DNA Contract Manufacturing Market, by Service Type 2019-2032 (USD Million)
  • TABLE Plasmid DNA Contract Manufacturing Market: Therapeutic Area Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global Plasmid DNA Contract Manufacturing Market, by Therapeutic Area 2019-2032 (USD Million)
  • TABLE Plasmid DNA Contract Manufacturing Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Plasmid DNA Contract Manufacturing Market, by Application 2019-2032 (USD Million)
  • TABLE Plasmid DNA Contract Manufacturing Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Plasmid DNA Contract Manufacturing Market, by Region 2019-2032 (USD Million)
  • TABLE North America Plasmid DNA Contract Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Plasmid DNA Contract Manufacturing Market, by Plasmid Size and Complexity, 2019-2032 (USD Million)
  • TABLE North America Plasmid DNA Contract Manufacturing Market, by Service Type, 2019-2032 (USD Million)
  • TABLE North America Plasmid DNA Contract Manufacturing Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE North America Plasmid DNA Contract Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Plasmid DNA Contract Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Plasmid DNA Contract Manufacturing Market, by Plasmid Size and Complexity, 2019-2032 (USD Million)
  • TABLE Europe Plasmid DNA Contract Manufacturing Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Europe Plasmid DNA Contract Manufacturing Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Europe Plasmid DNA Contract Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Plasmid DNA Contract Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Plasmid DNA Contract Manufacturing Market, by Plasmid Size and Complexity, 2019-2032 (USD Million)
  • TABLE Asia Pacific Plasmid DNA Contract Manufacturing Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Plasmid DNA Contract Manufacturing Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Asia Pacific Plasmid DNA Contract Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Plasmid DNA Contract Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Plasmid DNA Contract Manufacturing Market, by Plasmid Size and Complexity, 2019-2032 (USD Million)
  • TABLE Latin America Plasmid DNA Contract Manufacturing Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Latin America Plasmid DNA Contract Manufacturing Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Latin America Plasmid DNA Contract Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Plasmid DNA Contract Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Plasmid DNA Contract Manufacturing Market, by Plasmid Size and Complexity, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Plasmid DNA Contract Manufacturing Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Plasmid DNA Contract Manufacturing Market, by Therapeutic Area, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Plasmid DNA Contract Manufacturing Market, by Application, 2019-2032 (USD Million)
目次
Product Code: ANV2668

REPORT HIGHLIGHT

Plasmid DNA Contract Manufacturing Market size was valued at USD 381.54 Million in 2023, expanding at a CAGR of 19.43% from 2024 to 2032.

The Plasmid DNA Contract Manufacturing Market involves the outsourcing of production processes related to plasmid DNA, which is widely used in biotechnology and pharmaceutical research. The rising demand for gene therapy and vaccine development boosted the growth of contract manufacturing services for plasmid DNA. However, restraints such as regulatory challenges and the complexity of manufacturing processes pose hurdles to market expansion. Opportunities lie in the rising investments in biotechnology and the development of novel therapies, which create a conducive environment for contract manufacturers to capitalize on the growing demand for plasmid DNA.

Plasmid DNA Contract Manufacturing Market- Market Dynamics

The increasing demand for plasmid (pDNA) DNA and increasing research and development activities by key players in the market

The demand for plasmid DNA is witnessing a notable upsurge, driven by increasing research and development activities undertaken by prominent market players. This trend is indicative of the growing importance of plasmid DNA in various biotechnological applications, including gene therapy, vaccine development, and genetic engineering. Furthermore, contract manufacturing organizations are contributing to the expansion of the plasmid DNA market. These efforts are aimed at addressing unmet medical needs and driving innovation in the biotechnology sector.

Plasmid DNA Contract Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 19.43% over the forecast period (2024-2032)

Based on Plasmid Size and Complexity segmentation, Large Plasmids were predicted to show maximum market share in the year 2023

Based on Service Type segmentation, Plasmid DNA Manufacturing was the leading type in 2023

Based on Therapeutic Area segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Plasmid DNA Contract Manufacturing Market- Segmentation Analysis:

The Global Plasmid DNA Contract Manufacturing Market is segmented on the basis of Plasmid Size and Complexity, Service Type, Therapeutic Area, Application, and Region.

The market is divided into three categories based on Plasmid Size and Complexity: Plasmids come in different sizes and complexities, catering to various genetic engineering needs. Small plasmids are compact DNA molecules ideal for basic genetic engineering tasks, while large plasmids offer greater gene-carrying capacity, suiting advanced biotechnology applications.

The market is divided into four categories based on Service Type: Plasmid DNA contract manufacturing offers diverse services, including production, optimization, testing, and formulation. Analytical testing ensures product quality, while formulation and fill-finish services prepare products for distribution.

Plasmid DNA Contract Manufacturing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America leads in market share due to a strong presence of biotechnology and pharmaceutical companies, coupled with favorable regulatory frameworks. Europe follows closely, with robust investments in research and development and a well-established biomanufacturing infrastructure. The Asia-Pacific region shows significant growth potential, driven by increasing investments in biotechnology and contract manufacturing services.

Plasmid DNA Contract Manufacturing Market- Competitive Landscape:

Several key players include established biopharmaceutical contract manufacturing organizations (CMOs) such as Aldevron, Catalent, and Thermo Fisher Scientific. These companies offer comprehensive services ranging from plasmid DNA production to purification and analytical testing. Additionally, emerging CMOs and biotechnology startups contribute to market diversity, offering specialized expertise and niche services. Collaboration between contract manufacturers and biotechnology firms further intensifies competition, as companies strive to offer innovative solutions and expand their global footprint.

Recent Developments:

In March 2024, Novel Bio entered into a product development and scale-up agreement with Culture Biosciences to produce plasmid DNA. According to the agreement, Novel Bio will assist Culture Biosciences in expediting the development of scalable fermentation processes for their proprietary NBx Platform(TM), aimed at enhancing plasmid DNA production.

In June 2023, INADcure Foundation unveiled a manufacturing partnership with Charles River Laboratories. In this collaboration, Charles River Laboratories will oversee the production of high-quality plasmid DNA (pDNA) for phase I/II clinical trials focused on a gene therapy targeting Infantile Neuroaxonal Dystrophy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Aldevron, LLC

Catalent, Inc.

Cell and Gene Therapy Catapult (CGT Catapult)

Cobra Biologics (a subsidiary of Cognate BioServices)

Codex DNA, Inc.

Eurofins Scientific

Fujifilm Diosynth Biotechnologies

Kaneka Corporation

Lonza Group Ltd.

MilliporeSigma (a business of Merck KGaA)

PlasmidFactory GmbH & Co. KG

Sirion Biotech GmbH

Thermo Fisher Scientific Inc.

VGXI, Inc. (a subsidiary of GeneOne Life Science Inc.)

Wuxi Biologics

Others

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY PLASMID SIZE AND COMPLEXITY- MARKET ANALYSIS, 2019 - 2032

  • Small Plasmids
  • Large Plasmids
  • Complex Plasmids (e.g., viral vectors)

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Plasmid DNA Manufacturing
  • Process Development and Optimization
  • Analytical Testing and Quality Control
  • Formulation and Fill-Finish Services
  • Others

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Genetic Disorders
  • Infectious Diseases
  • Rare Diseases
  • Autoimmune Disorders
  • Others

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Gene Therapy
  • Vaccines
  • Cell Therapy
  • Protein Production
  • Research and Development
  • Others

GLOBAL PLASMID DNA CONTRACT MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Plasmid DNA Contract Manufacturing Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Plasmid DNA Contract Manufacturing Market Snippet by Plasmid Size and Complexity
    • 2.1.2.Plasmid DNA Contract Manufacturing Market Snippet by Service Type
    • 2.1.3.Plasmid DNA Contract Manufacturing Market Snippet by Therapeutic Area
    • 2.1.4.Plasmid DNA Contract Manufacturing Market Snippet by Application
    • 2.1.5.Plasmid DNA Contract Manufacturing Market Snippet by Country
    • 2.1.6.Plasmid DNA Contract Manufacturing Market Snippet by Region
  • 2.2.Competitive Insights

3.Plasmid DNA Contract Manufacturing Key Market Trends

  • 3.1.Plasmid DNA Contract Manufacturing Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Plasmid DNA Contract Manufacturing Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Plasmid DNA Contract Manufacturing Market Opportunities
  • 3.4.Plasmid DNA Contract Manufacturing Market Future Trends

4.Plasmid DNA Contract Manufacturing Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Plasmid DNA Contract Manufacturing Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Plasmid DNA Contract Manufacturing Market Landscape

  • 6.1.Plasmid DNA Contract Manufacturing Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Plasmid DNA Contract Manufacturing Market - By Plasmid Size and Complexity

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Plasmid Size and Complexity, 2023 & 2032 (%)
    • 7.1.2.Small Plasmids
    • 7.1.3.Large Plasmids
    • 7.1.4.Complex Plasmids (e.g., viral vectors)

8.Plasmid DNA Contract Manufacturing Market - By Service Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Service Type, 2023 & 2032 (%)
    • 8.1.2.Plasmid DNA Manufacturing
    • 8.1.3.Process Development and Optimization
    • 8.1.4.Analytical Testing and Quality Control
    • 8.1.5.Formulation and Fill-Finish Services
    • 8.1.6.Others

9.Plasmid DNA Contract Manufacturing Market - By Therapeutic Area

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Genetic Disorders
    • 9.1.4.Infectious Diseases
    • 9.1.5.Rare Diseases
    • 9.1.6.Autoimmune Disorders
    • 9.1.7.Others

10.Plasmid DNA Contract Manufacturing Market - By Application

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Service Type, 2023 & 2032 (%)
    • 10.1.2.Gene Therapy
    • 10.1.3.Vaccines
    • 10.1.4.Cell Therapy
    • 10.1.5.Protein Production
    • 10.1.6.Research and Development
    • 10.1.7.Others

11.Plasmid DNA Contract Manufacturing Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Plasmid DNA Contract Manufacturing Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Plasmid DNA Contract Manufacturing Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Plasmid DNA Contract Manufacturing Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Plasmid DNA Contract Manufacturing Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Plasmid DNA Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Plasmid Size and Complexity, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Plasmid DNA Contract Manufacturing Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Aldevron, LLC
    • 12.2.2.Catalent, Inc.
    • 12.2.3.Cell and Gene Therapy Catapult (CGT Catapult)
    • 12.2.4.Cobra Biologics (a subsidiary of Cognate BioServices)
    • 12.2.5.Codex DNA, Inc.
    • 12.2.6.Eurofins Scientific
    • 12.2.7.Fujifilm Diosynth Biotechnologies
    • 12.2.8.Kaneka Corporation
    • 12.2.9.Lonza Group Ltd.
    • 12.2.10.MilliporeSigma (a business of Merck KGaA)
    • 12.2.11.PlasmidFactory GmbH & Co. KG
    • 12.2.12.Sirion Biotech GmbH
    • 12.2.13.Thermo Fisher Scientific Inc.
    • 12.2.14.VGXI, Inc. (a subsidiary of GeneOne Life Science Inc.)
    • 12.2.15.Wuxi Biologics
    • 12.2.16.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us